HOME >> MEDICINE >> NEWS
Survey of adults reveals life-long consequences of ADHD

NEW YORK, May 6 -- Adults with attention-deficit/hyperactivity disorder (ADHD) may have grown up with the condition, but have they outgrown its effects? Findings from a new national survey, "Capturing America's Attention," indicate that adults with ADHD experience life-long impairments in several facets of their lives, including educational and professional achievements, self-image and interpersonal relationships. This survey is the first to examine the long-term impact of ADHD among 1,001 adults. Results were presented today at the American Psychiatric Association (APA) annual meeting.

While the exact number of adults with ADHD is unknown, it is estimated that four percent of the U.S. adult population is affected by ADHD. The survey found that the repercussions of ADHD may prohibit adults with the condition from reaching their full academic and occupational potential, and limit their satisfaction with themselves and their relationships.

"The importance of diagnosing and helping adults with ADHD has often been debated by individuals, health care professionals and by society in general," saidJoseph Biederman, M.D., Professor of Psychiatry, Harvard Medical School and Chief of Pediatric Psychopharmacology at Massachusetts General Hospital. "The compelling results of this survey reinforce the fact that ADHD is a serious medical condition causing significant, life-long impairments. ADHD can no longer be dismissed as a 'fake' or 'made-up' disorder."

Negative Self-Image and Harmful Behaviors
Adults with ADHD are three times more likely to suffer from stress, depression or other problems with emotion. These emotional and physical effects can cause people with ADHD to "lose" days of their lives. "Lost days" may manifest as a day absent from work or several times throughout the month when the person is not fully engaged both physically and emotionally. About one in four (24 percent) adults with ADHD said that on 11 days per month
'"/>

Contact: Porter Novelli, Elizabeth Pallotta
epallotta@porternovelli.com
212-601-8134
Porter Novelli
6-May-2004


Page: 1 2 3 4

Related medicine news :

1. Survey suggests majority of women surgeons satisfied in their profession
2. Survey highlights myth of multi-faith chaplaincy in hospitals
3. Survey provides comprehensive look at use of complementary and alternative medicine in US
4. Survey shows new Mayo Clinic treatment for intractable low blood pressure
5. Survey shows impact of psoriasis is more than skin deep
6. Survey on total cardiovascular risk shows significant gap between patient education and action
7. Survey of medical students affirms value of student diversity
8. Survey shows benefits of prescription drug advertising, few adverse effects
9. Surveys find chronic conditions a widespread concern
10. Survey: Medicare gets higher marks from enrollees than private insurance
11. Survey reveals needs of glaucoma patients across Europe

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Survey adults reveals life long consequences ADHD

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: